VNDA vs VNO · rev $102.2M vs rev $921.3M
Vanda Pharmaceuticals Inc (VNDA) versus VNO (VNO) — a side-by-side from cached financials, not a winner call.
Vanda Pharmaceuticals Inc (VNDA) is a biotechnology company listed on NASDAQ.
VNO (VNO) common stock.
Latest reported VNDA revenue for 2026-06-30 was $102.2M. Net income was -$111.1M. Revenue was up 97.7% from 2026-03-31 to 2026-06-30. VNDA currently screens at market cap $358.4M.
Latest reported VNO revenue for 2026-06-30 was $921.3M. Net income was $24.6M. VNO currently screens at market cap $0.
VNDA currently screens at market cap $358.4M. VNO currently screens at market cap $0.
Not investment advice. Open the VNDA and VNO stock pages for the full models.
Not investment advice.